Vergelijking

Pasireotid vs. Sekretin

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

396091-73-9

geen gegevens

Molecuulmassa

1047.21 g/mol

3055.5 g/mol

Halfwaardetijd

geen gegevens

Sequentie

geen gegevens

Werkingsmechanisme

Pasireotid

Pasireotide binds more broadly than older somatostatin analogs (SSTR1/2/3/5) with particularly high affinity for SSTR5. This suppresses, among others, ACTH release in Cushing's disease and GH release in acromegaly.

Sekretin

Secretin binds the Gs-coupled secretin receptor (SCTR) on pancreatic duct cells, opens CFTR chloride channels and triggers secretion of bicarbonate-rich pancreatic fluid and bile flow.

Bewijsbasis

Hoogste bewijs

Humane RCT

Humane studie

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Pasireotid	Sekretin
Duitsland	Op recept	Op recept
Verenigde Staten	Op recept	Op recept

Volledige vermeldingen

Pasireotid

Volledige vermelding →

Sekretin

Volledige vermelding →

Frequently asked questions

What is the difference between Pasireotid and Sekretin?: Pasireotid is classified as "Onderzoek (overig)", while Sekretin is classified as "Onderzoek (overig)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Sekretin: Secretin is a 27-amino-acid hormone that regulates pancreatic bicarbonate secretion. As ChiRhoStim it is FDA-approved as a diagnostic agent (pancreatic function test, gastrinoma test, secretin-enhanced MRCP). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Pasireotid or Sekretin?: The highest available evidence level is "Humane RCT" for Pasireotid and "Humane studie" for Sekretin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Pasireotid and Sekretin in Germany and the United States?: Duitsland: Pasireotid — Op recept, Sekretin — Op recept. Verenigde Staten: Pasireotid — Op recept, Sekretin — Op recept. These are factual summaries with source and review date on the individual pages.

Country

Pasireotid

Sekretin

Duitsland

Op recept

Verenigde Staten

Op recept

Frequently asked questions

What is the difference between Pasireotid and Sekretin?

Pasireotid is classified as "Onderzoek (overig)", while Sekretin is classified as "Onderzoek (overig)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Sekretin: Secretin is a 27-amino-acid hormone that regulates pancreatic bicarbonate secretion. As ChiRhoStim it is FDA-approved as a diagnostic agent (pancreatic function test, gastrinoma test, secretin-enhanced MRCP). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Pasireotid or Sekretin?

The highest available evidence level is "Humane RCT" for Pasireotid and "Humane studie" for Sekretin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Pasireotid and Sekretin in Germany and the United States?

Duitsland: Pasireotid — Op recept, Sekretin — Op recept. Verenigde Staten: Pasireotid — Op recept, Sekretin — Op recept. These are factual summaries with source and review date on the individual pages.